Korean J Anesthesiol.  1997 Jun;32(6):940-945. 10.4097/kjae.1997.32.6.940.

Neuromuscular Blocking Action of Neostigmine Methylsulfate

Affiliations
  • 1Department of Anesthesiology, College of Medicine, Soon Chun Hyang University, Seoul, Korea.
  • 2Department of Anesthesiology, College of Medicine, Seoul National University, Seoul, Korea.

Abstract

BACKGROUND
Although the neuromuscular blocking properties of neostigmine have been known for many years, few assessment of this effect has been described in man. The aim of this study is to determine the effect of neostigmine on neuromuscular transmission in the absence of muscle relaxants.
METHODS
ASA I, twenty unpremedicated patients who had given their informed consent were administered neostigmine 2.0 mg and atropine 0.5 mg under propofol, fentanyl, and O2-N2O(67%) anesthesia. Train-of-four responses were measured electromyographically using 0.2 msec, 2 Hz of supramaximal ulnar nerve stimulation every 20 sec.
RESULTS
There was no alteration in the train-of-four ratio, but the first twitch height decreased significantly after administration of neostigmine(P<0.05). Fasciculations were noted in the face and arms. Heart rate was decreased significantly to compare with preinjection value(P<0.05) while mean arterial pressure was not changed.
CONCLUSIONS
It is concluded that even in clinical doses neostigmine may produce a depolarizing neuromuscular blockade, probably from the consequence of excessive accumulation of acetylcholine in the neuromuscular junction.

Keyword

Monitoring; train of four stimulation; Neuromuscular block; neostigmine

MeSH Terms

Acetylcholine
Anesthesia
Arm
Arterial Pressure
Atropine
Fasciculation
Fentanyl
Heart Rate
Humans
Informed Consent
Neostigmine*
Neuromuscular Blockade*
Neuromuscular Junction
Propofol
Ulnar Nerve
Acetylcholine
Atropine
Fentanyl
Neostigmine
Propofol
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr